357 related articles for article (PubMed ID: 8413587)
1. Dopamine D4 receptors elevated in schizophrenia.
Seeman P; Guan HC; Van Tol HH
Nature; 1993 Sep; 365(6445):441-5. PubMed ID: 8413587
[TBL] [Abstract][Full Text] [Related]
2. Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata.
Seeman P; Guan HC; Van Tol HH; Niznik HB
Synapse; 1993 Aug; 14(4):247-53. PubMed ID: 8248849
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D2-like sites in schizophrenia, but not in Alzheimer's, Huntington's, or control brains, for [3H]benzquinoline.
Seeman P; Guan HC; Nobrega J; Jiwa D; Markstein R; Balk JH; Picetti R; Borrelli E; Van Tol HH
Synapse; 1997 Feb; 25(2):137-46. PubMed ID: 9021894
[TBL] [Abstract][Full Text] [Related]
4. Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression.
Sumiyoshi T; Stockmeier CA; Overholser JC; Thompson PA; Meltzer HY
Brain Res; 1995 May; 681(1-2):109-16. PubMed ID: 7552267
[TBL] [Abstract][Full Text] [Related]
5. Are striatal dopamine D4 receptors increased in schizophrenia?
Reynolds GP; Mason SL
J Neurochem; 1994 Oct; 63(4):1576-7. PubMed ID: 7931313
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D4-like receptor elevation in schizophrenia: cloned D2 and D4 receptors cannot be discriminated by raclopride competition against [3H]nemonapride.
Seeman P; Van Tol HH
J Neurochem; 1995 Mar; 64(3):1413-5. PubMed ID: 7861175
[TBL] [Abstract][Full Text] [Related]
7. Distribution of dopamine D1 and D2 receptors in rabbit cortical areas, hippocampus, and neostriatum in relation to dopamine contents.
Dewar KM; Reader TA
Synapse; 1989; 4(4):378-86. PubMed ID: 2532424
[TBL] [Abstract][Full Text] [Related]
8. Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia.
Murray AM; Hyde TM; Knable MB; Herman MM; Bigelow LB; Carter JM; Weinberger DR; Kleinman JE
J Neurosci; 1995 Mar; 15(3 Pt 2):2186-91. PubMed ID: 7891160
[TBL] [Abstract][Full Text] [Related]
9. Dopamine receptors and the dopamine hypothesis of schizophrenia.
Seeman P
Synapse; 1987; 1(2):133-52. PubMed ID: 2905529
[TBL] [Abstract][Full Text] [Related]
10. Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain.
Seeman P; Guan HC; Niznik HB
Synapse; 1989; 3(1):96-7. PubMed ID: 2521961
[No Abstract] [Full Text] [Related]
11. Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia.
Joyce JN; Lexow N; Bird E; Winokur A
Synapse; 1988; 2(5):546-57. PubMed ID: 2973147
[TBL] [Abstract][Full Text] [Related]
12. Zinc modulates antagonist interactions with D2-like dopamine receptors through distinct molecular mechanisms.
Schetz JA; Chu A; Sibley DR
J Pharmacol Exp Ther; 1999 May; 289(2):956-64. PubMed ID: 10215675
[TBL] [Abstract][Full Text] [Related]
13. Dopamine receptor pharmacology.
Seeman P; Van Tol HH
Curr Opin Neurol Neurosurg; 1993 Aug; 6(4):602-8. PubMed ID: 8104554
[TBL] [Abstract][Full Text] [Related]
14. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.
Seeman P; Niznik HB; Guan HC; Booth G; Ulpian C
Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10156-60. PubMed ID: 2574862
[TBL] [Abstract][Full Text] [Related]
15. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
Millan MJ; Newman-Tancredi A; Brocco M; Gobert A; Lejeune F; Audinot V; Rivet JM; Schreiber R; Dekeyne A; Spedding M; Nicolas JP; Peglion JL
J Pharmacol Exp Ther; 1998 Oct; 287(1):167-86. PubMed ID: 9765336
[TBL] [Abstract][Full Text] [Related]
16. Receptor-receptor link in membranes revealed by ligand competition: example for dopamine D1 and D2 receptors.
Seeman P; Sunahara RK; Niznik HB
Synapse; 1994 May; 17(1):62-4. PubMed ID: 8042146
[TBL] [Abstract][Full Text] [Related]
17. Schizophrenia: elevation of dopamine D4-like sites, using [3H]nemonapride and [125I]epidepride.
Seeman P; Guan HC; Van Tol HH
Eur J Pharmacol; 1995 Nov; 286(2):R3-5. PubMed ID: 8605946
[TBL] [Abstract][Full Text] [Related]
18. Association study between antipsychotics- induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia.
Kang SG; Lee HJ; Choi JE; Park YM; Park JH; Han C; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
Neuropsychobiology; 2008; 57(1-2):49-54. PubMed ID: 18451638
[TBL] [Abstract][Full Text] [Related]
19. In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-(+)-PHNO in rats using an intracerebral beta-sensitive system.
Galineau L; Wilson AA; Garcia A; Houle S; Kapur S; Ginovart N
Synapse; 2006 Aug; 60(2):172-83. PubMed ID: 16715499
[TBL] [Abstract][Full Text] [Related]
20. Dopamine displaces [3H]domperidone from high-affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: Implications for human positron emission tomography.
Seeman P; Tallerico T; Ko F
Synapse; 2003 Sep; 49(4):209-15. PubMed ID: 12827639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
